Charles Harrington

Medicine & Life Sciences

1. Alzheimer Disease 100%
2. tau Proteins 65%
3. Tauopathies 48%
4. Transgenic Mice 28%
5. leucomethylene blue 26%
6. Frontotemporal Dementia 24%
7. Brain 24%
8. Synucleins 23%
9. Neurofibrillary Tangles 23%
10. Pathology 22%
11. Rivastigmine 18%
12. Synucleinopathies 18%
13. Methylene Blue 18%
14. Mesylates 15%
15. Amyloid 13%
16. Frontotemporal Lobar Degeneration 12%
17. Dementia 12%
18. Atrophy 11%
19. Parkinson Disease 11%
20. Neurodegenerative Diseases 11%
21. Phosphorylation 11%
22. urinary gonadotropin fragment 11%
23. In Vitro Techniques 11%
24. phenothiazine 11%
25. Psychological Inhibition 10%
26. Cognitive Dysfunction 10%
27. Proteins 10%
28. Therapeutics 10%
29. dityrosine 10%
30. Cholinergic Agents 10%
31. Salts 10%
32. Prions 9%
33. Memantine 9%
34. alpha-Synuclein 9%
35. thiazin red 9%
36. Neurons 8%
37. Progressive Supranuclear Palsy 8%
38. Phase III Clinical Trials 8%
39. Phenotype 7%
40. Pharmaceutical Preparations 7%
41. Amyloid Plaques 7%
42. Lewy Bodies 6%
43. Neuroblastoma 6%
44. Pick Disease of the Brain 6%
45. poly-U binding splicing factor 60KDa 6%
46. Basal Forebrain 5%
47. Acetylcholine 5%
48. Temporal Lobe 5%
49. Lewy Body Variant of Alzheimer Disease 5%
50. Scopolamine 5%